Abstract
Background: Salvage surgery for anal cancer is usually reserved for local disease failure, but issues relating to the prediction of local failure and surgical outcome are ill defined. Methods: Between 1988 and 2000, 254 patients with non-metastatic anal epidermoid carcinoma were treated at a regional cancer centre with radiotherapy (n = 127) or chemoradiotherapy (n = 127). Results: There were 99 local disease failures (39.0 per cent), all but five occurring within 3 years of initial treatment. Increasing age (P <0.001, Cox model), total radiation dose (P = 0.004) and tumour stage (P = 0.010) were independent predictors of local failure. The overall 3- and 5-year survival rates after local disease failure were 46 and 29 per cent; the corresponding rates after salvage surgery (73 patients) were 55 and 40 per cent. A positive resection margin was the strongest negative predictor of survival after salvage surgery (P = 0.008, log rank test). Of 52 patients treated before the routine consideration of primary plastic reconstruction, delayed perineal wound healing occurred in 22 (42 per cent). Conclusion: In the management of anal cancer, local disease failure is a major clinical problem requiring early detection followed by radical surgery, often accompanied by plastic reconstruction. By implication, these factors favour the centralization of treatment for this uncommon cancer to a multidisciplinary oncology team. Copyright © 2005 British Journal of Surgery Society Ltd.
Original language | English |
---|---|
Pages (from-to) | 605-614 |
Number of pages | 9 |
Journal | British Journal of Surgery |
Volume | 92 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2005 |
Keywords
- Adult
- Aged
- Aged, 80 and over
- drug therapy: Anus Neoplasms
- drug therapy: Carcinoma, Squamous Cell
- methods: Colostomy
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Neoplasm, Residual
- etiology: Postoperative Complications
- Proportional Hazards Models
- Prospective Studies
- methods: Salvage Therapy
- Survival Analysis
- Treatment Failure
- Treatment Outcome